What to know
On July 19, 2024, CDC issued Emergency Use Instructions (EUI) for an antiviral called oseltamivir, generic for brand name drug Tamiflu, for treatment or post-exposure prophylaxis (PEP) of pandemic influenza A viruses and novel influenza A viruses with pandemic potential.
About EUI
EUI provide information about emergency use of FDA-approved medical products that differ from or go beyond the information provided in the FDA-approved labeling (package insert). CDC-issued oseltamivir EUI fact sheets for healthcare providers and recipients and caregivers are available below.
Oseltamivir Emergency Use Instructions (EUI) Fact Sheet for Healthcare Providers
Oseltamivir Emergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers
Oseltamivir Emergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers (Spanish)
Oseltamivir Emergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers (Haitian Creole)
Emergency Use Instructions (EUI) Fact Sheet for Healthcare Providers: Oseltamivir for Treatment or P...
Emergency Use Instructions (EUI) Fact Sheet for Healthcare Providers: Oseltamivir for Treatment or P...